Welcome to the News & More section. Here you will find general information in the form of press releases, news and the latest graphical material.
Berlin-Chemie has been developing, manufacturing and distributing pharmaceutical products for over 130 years and has been a wholly owned subsidiary of the Menarini Group, the leading Italian pharmaceutical company, since 1992.
For patients, we provide the latest patient information leaflets and training materials as well as the technical information for Berlin-Chemie products available in Germany via our Medical Hub.
Responsibility is a top priority at Berlin-Chemie. We not only make an important contribution to healthcare, but also put our values into practice through various social initiatives.
Discover More about Global Responsibility
From school kits to free meals and medicines, to caring for the environment around the world. In Menarini, being responsible means translating our values into concrete actions that are good for others and good for the planet
Berlin-Chemie – a strong partner. Our many years of experience and the success of joint projects make us the partner of choice.
Discover More about Global Partnering
Menarini has in-depth know-how in many important therapeutic areas, thanks to many years of excellent market introduction, marketing and sales capabilities as well as expertise in regulatory aspects and market access. Collaboration is the key to great success, and at Menarini, partnership is part of the DNA.
Our holistic and professional health management offers doctors individual counselling, training or workshops, events and lectures on many topics, depending on their needs.
Our Medical Hub acts as a central point of contact for doctors and healthcare professionals. Here you will find all the information about our medications, additional service and training opportunities.
Menarini Blog
Follow Us
We employ professionals with a wide variety of career backgrounds and are employers who care about their staff. Together, we stand for innovation and reliability.
Our Job Portal
Find out about our current vacancies at Berlin-Chemie directly on our career portal.
Migraine
Medical practitioners divide headaches into primary and secondary headaches. Whilst secondary headaches are due to other physical causes, this is not the case for primary headaches. Migraine is classed as a primary headache.
According to the latest study data from 2020 14.8% of women and 6.0% of men in Germany meet the criteria for migraine1. It is not yet known precisely what causes migraine, and lifestyle and hormonal changes may play a role in addition to genetic predisposition. The symptoms vary considerably and include throbbing headaches, frequently on one side of the body, nausea and vomiting as well as hypersensitivity to light and sound over a period of at least 4 to 72 hours. A one-sided migraine headache may switch from one side to another during an attack and may even become more severe during physical activity, unlike tension headaches. Because of the various concomitant symptoms of the migraine, it prevents most people from going about their normal daily activities.
Some of those affected also have a migraine with aura. This aura comprises neurological deficits such as visual disturbances, flickering, flashes of light and visual field loss and may even include sensory disturbances, speech disorders or aphasia.
The goal of pharmaceutical treatment for migraine is to alleviate the headache and concomitant symptoms such as nausea and vomiting etc. A range of medication is available. In addition to medication, migraine patients should ideally be protected from stimuli during an attack and remain in a quiet, darkened room.
Sources:
1 Gesundheitsberichterstattung/GBEDownloadsJ/JoHM_S6_2020_Migraene_Spannungskopfschmerz.pdf (Last accessed: 22.01.2024)